Prognosis
Common Painkiller Tested Against Covid-19 in U.K. Study
- Scientists investigating Flarin, a version of ibuprofen
- Study uses a different kind of ibuprofen than is common
This article is for subscribers only.
Scientists in London are testing whether a common painkiller can help patients with Covid-19 avoid potentially lethal respiratory failure and the need for mechanical ventilators.
The study uses a type of ibuprofen called Flarin that’s available in the U.K. and formulated differently than the standard version to protect the stomach. The study is being run by Guy’s and St. Thomas’ NHS Foundation Trust, King’s College London and SEEK, a proprietary drug-research firm.